Synonym
L 659874; L-659874; L659874;
IUPAC/Chemical Name
(S)-2-((S)-2-((S)-2-acetamido-4-methylpentanamido)-4-(methylthio)butanamido)-N1-((S)-1-(((S)-1-((2-amino-2-oxoethyl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)pentanediamide
InChi Key
RDESGNZZHYRWNM-ZTTXAYQISA-N
InChi Code
1S/C40H55N9O8S/c1-23(2)18-31(45-24(3)50)39(56)47-30(16-17-58-4)38(55)46-29(14-15-34(41)51)37(54)49-33(20-26-21-43-28-13-9-8-12-27(26)28)40(57)48-32(36(53)44-22-35(42)52)19-25-10-6-5-7-11-25/h5-13,21,23,29-33,43H,14-20,22H2,1-4H3,(H2,41,51)(H2,42,52)(H,44,53)(H,45,50)(H,46,55)(H,47,56)(H,48,57)(H,49,54)/t29-,30-,31-,32-,33-/m0/s1
SMILES Code
CC(C[C@H](NC(C)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N)=O)=O)Cc1ccccc1)=O)Cc2c3ccccc3[nH]c2)=O)CCC(N)=O)=O)CCSC)=O)C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
821.99
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Munro FE, Fleetwood-Walker SM, Parker RM, Mitchell R. The effects of neurokinin receptor antagonists on mustard oil-evoked activation of rat dorsal horn neurons. Neuropeptides. 1993 Nov;25(5):299-305. PubMed PMID: 8115032.
2: Fleetwood-Walker SM, Parker RM, Munro FE, Young MR, Hope PJ, Mitchell R. Evidence for a role of tachykinin NK2 receptors in mediating brief nociceptive inputs to rat dorsal horn (laminae III-V) neurons. Eur J Pharmacol. 1993 Sep 28;242(2):173-81. PubMed PMID: 8253113.
3: Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol. 1993 Sep;110(1):43-9. PubMed PMID: 7693287; PubMed Central PMCID: PMC2176009.
4: Hall JM, Flowers JM, Morton IK. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Br J Pharmacol. 1992 Nov;107(3):777-84. PubMed PMID: 1282072; PubMed Central PMCID: PMC1907736.
5: Suman-Chauhan N, Guard S, Williams BJ, Watling KJ. Pharmacological characterization of tachykinin-stimulated inositol phospholipid hydrolysis in peripheral tissues. Br J Pharmacol. 1990 Dec;101(4):1001-5. PubMed PMID: 1707702; PubMed Central PMCID: PMC1917849.
